Teleflex Incorporated

Teleflex Incorporated

TFX

Get informed when a big investor buys or sells

+ Follow
Market Cap$5.69B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Teleflex IncorporatedTeleflex Incorporated-5.61.06%-33%3.10.1
$144.00

Target Price by Analysts

12% upsideTeleflex Incorporated Target Price DetailsTarget Price
$123.45

Current Fair Value

4% downside

Overvalued by 4% based on the discounted cash flow analysis.

Share Statistics

Market cap$5.69 Billion
Enterprise Value$5.57 Billion
Dividend Yield$1.36 (1.06%)
Earnings per Share$-20.3
Beta0.82
Outstanding Shares44,257,000

Return

Return on Equity-32.71%ROE
Return on Assets-14.87%
Return on Invested Capital1.88%

Valuation & Multiples

P/E Ratio-5.64P/E Ratio
PEG5.2PEG
Price to Sales3.14Price to Sales
Price to Book Ratio1.86Price to Book Ratio
Enterprise Value to Revenue3.03
Enterprise Value to EBIT48.84
Enterprise Value to Net Income-6
Total Debt to Enterprise0.03
Debt to Equity0.06Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 7, 2026
EPS Estimate
$1.21
Average shareholder expectation
Revenue Estimate
$536.91 M
Average shareholder expectation

Next Earnings Call

Expected Date
July 30, 2026
EPS Estimate
$1.29
Average shareholder expectation
Revenue Estimate
$559.03 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.4365 67.58%
Total Calls54,300 35.41%
Total Puts23,700 46.86%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %107.22% 0.55%
Total Invested$5.72B 0.10%
Investors Holding370 40.00%

ESG Score

No data

About Teleflex Incorporated

CEO: Liam Kelly

Relevant Senate Committees

Joint Committee on Taxation

This committee provides the official revenue estimates and technical analysis for all tax legislation, directly influencing corporate tax structures and capital investment credits which are critical for TFX's financial planning and performance.

Finance

This committee controls taxation, trade, and entitlement spending (e.g., Medicare). Tax policy directly impacts TFX's profitability, and Medicare pricing and coverage decisions are critical for the medical device industry's revenue streams.

Appropriations

This committee directly allocates federal spending to government agencies and programs, including healthcare initiatives and research (e.g., NIH, VA), which can significantly impact demand and funding for TFX's products.

Health, Education, Labor, and Pensions

This committee directly regulates the FDA, which is the primary regulatory body for medical devices, and influences labor laws affecting manufacturing costs, making it highly relevant to TFX.

Veterans' Affairs

This committee's funding decisions for the Department of Veterans Affairs directly impact government healthcare contractors and the demand for medical devices, making it a significant influence on TFX.